A controlled clinical study on efficacy and safety of periocular triamcinolone acetonide injection for treating ocular myasthenia gravis.

"Declarations Ethics approval and consent to participateThe study was performed in accordance with the Declaration of Helsinki and was approved by the ethics committee of Aier Eye Hospital of Wuhan University, China (approval no.: HYEYE2019IRB05). Written informed consent was obtained from each patient or their parents (for children < 18 years of age) prior to participation in the study. Consent for publicationWe have obtained explicit written informed consent to publish all data (including individual details, images or videos) related to the study from patients or their parents. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This study was supported in part by Research Fund of Aier Eye Hospital Group,Project No: AF2108D6.The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. None of authors have any financial interest in any of the material described herein."

"Clinical Trial Registry: This study has been clinically registered by Chinese Clinical Trial Registry (ChiCTR), first trial registration date:05/07/2019, registration number: ChiCTR1900024285."